Who is sponsoring NCT05057078?

NCT05057078 is sponsored by Ankara University.

What drugs are being tested in NCT05057078?

Interventions in NCT05057078: mindfulness-based stress reduction program.

What condition does NCT05057078 study?

NCT05057078 studies Breast Cancer, Nursing Caries.

Is NCT05057078 still recruiting?

NCT05057078 is currently completed. Last updated 7 March 2023.

Last reviewed 2023-03-07 · How we verify

NCT05057078

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Mindfulness Program on Spiritual Well-BeingBreast Cancer Patients

Completed NA Last updated 7 March 2023

What this trial tests

NA trial testing mindfulness-based stress reduction program in Breast Cancer in 70 participants. Completed in 30 June 2022.

Timeline

29 September 2021

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Ankara University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	70
Start date	29 September 2021
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

mindfulness-based stress reduction program

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Nursing Caries — all drugs for Nursing Caries →

Sponsor

Ankara University

Who can join

Adults 18 to 65, female only, with Breast Cancer or Nursing Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer ranks first among the cancers seen in women in the World. Due to breast cancer, patients experience spiritual distress. The aim of this study is to determine the effect of mindfulness-based stress reduction program applied to patients with breast cancer on spiritual well-being.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of mindfulness-based therapy on spiritual well-being in breast cancer patients: a randomized controlled study.
Oner Cengiz H, Bayir B, Sayar S, Demirtas M. · · 2023 · cited 9× · PMID 37395841 · DOI 10.1007/s00520-023-07904-2

Verify or expand the search:

Other trials of mindfulness-based stress reduction program

Trials testing the same drug.

NCT06892509 — The Effect of Mindfulness Practice on Quality of Life, Life Satisfaction, Sleep Quality and Mental Well-being Levels in · NA · completed
NCT05877287 — Effect of Awareness-Based Stress Reducatıon Program Applıed to Parents Wıth A Chıld Wıth Autısm · NA · completed

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05057078 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 7 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05057078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing